Cetera Trust Company, N.A Neurocrine Biosciences Inc Transaction History
Cetera Trust Company, N.A
- $166 Billion
- Q1 2024
A detailed history of Cetera Trust Company, N.A transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Cetera Trust Company, N.A holds 2,190 shares of NBIX stock, worth $313,827. This represents 0.18% of its overall portfolio holdings.
Number of Shares
2,190
Previous 2,315
5.4%
Holding current value
$313,827
Previous $305 Million
0.98%
% of portfolio
0.18%
Previous 0.19%
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
629Shares Held
94.4MCall Options Held
505KPut Options Held
343K-
Black Rock Inc. New York, NY13.8MShares$1.97 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.93MShares$1.42 Billion0.03% of portfolio
-
State Street Corp Boston, MA3.99MShares$572 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.3MShares$329 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.25MShares$323 Million0.49% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.7B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...